What should a CMA monitor for after a patient receives insulin?

Monitoring for signs of hypoglycemia after a patient receives insulin is essential because insulin lowers blood glucose levels. If too much insulin is administered or if the patient does not eat adequately after receiving insulin, their blood glucose levels can drop significantly, leading to hypoglycemia. Symptoms of hypoglycemia can include shakiness, sweating, confusion, dizziness, irritability, and, in severe cases, loss of consciousness or seizures.

Understanding the significance of this monitoring helps ensure patient safety and well-being and allows for prompt intervention if signs of low blood sugar occur. This is critical in the context of medication administration where the administration of insulin directly influences blood glucose management and patient health outcomes.